Conference Coverage

This symptom signals UTI in 83% of cases


 

TOPLINE:

Dyspareunia is a major indicator of urinary tract infections, being present in 83% of cases. The symptom is especially accurate at identifying UTIs in nonmenopausal women, researchers have found.


METHODOLOGY:

  • Dyspareunia is a common symptom of UTIs, especially in premenopausal women, but is rarely inquired about during patient evaluations, according to researchers from Florida Atlantic University.
  • In 2010, the researchers found that among 3,000 of their female Latinx patients aged 17-72 years in South Florida, 80% of those with UTIs reported experiencing pain during sexual intercourse.
  • Since then, they have studied an additional 2,500 patients from the same population.

TAKEAWAY:

  • Among all 5,500 patients, 83% of those who had UTIs experienced dyspareunia.
  • Eighty percent of women of reproductive age with dyspareunia had an undiagnosed UTI.
  • During the perimenopausal and postmenopausal years, dyspareunia was more often associated with genitourinary syndrome than UTIs.
  • Ninety-four percent of women with UTI-associated dyspareunia responded positively to antibiotics.

IN PRACTICE:

“We have found that this symptom is extremely important as part of the symptomatology of UTI [and is] frequently found along with the classical symptoms,” the researchers reported. “Why has something so clear, so frequently present, never been described? The answer is simple: Physicians and patients do not talk about sex, despite dyspareunia being more a clinical symptom than a sexual one. Medical schools and residency programs in all areas, especially in obstetrics and gynecology, urology, and psychiatry, have been neglecting the education of physicians-in-training in this important aspect of human health. In conclusion, this is [proof] of how medicine has sometimes been influenced by religion, culture, and social norms far away from science.”

SOURCE:

The data were presented at the 2023 meeting of the Menopause Society. The study was led by Alberto Dominguez-Bali, MD, from Florida Atlantic University, Boca Raton, Fla.

LIMITATIONS:

The study authors reported no limitations.

DISCLOSURES:

The authors reported no relevant financial relationships.

A version of this article first appeared on Medscape.com.

Recommended Reading

Early menopause, delayed HT tied to Alzheimer’s pathology
Federal Practitioner
Best practices document outlines genitourinary applications of lasers and energy-based devices
Federal Practitioner
BMI has greater impact on survival in younger breast cancer patients
Federal Practitioner
FDA approves new drug to manage menopausal hot flashes
Federal Practitioner
Should you prescribe bioidentical hormones for menopause?
Federal Practitioner
Menopause and long COVID: What women should know
Federal Practitioner
Nitroglycerin patches do not improve menopause symptoms
Federal Practitioner
Hormone therapies still ‘most effective’ in treating menopausal vasomotor symptoms
Federal Practitioner
A ‘one-stop shop’: New guidance on hormones and aging
Federal Practitioner
Does ‘skeletal age’ describe fracture impact on mortality?
Federal Practitioner